Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Teruhiko, Miyazaki"'
Autor:
Mayumi Tsukiyama, Hiroaki Ohta, Akira Taguchi, Teruhiko Miyazaki, Masao Fukunaga, Toshitaka Nakamura, Hiroshi Hagino, Hajime Orimo, Masataka Shiraki, Satoshi Mori, Satoshi Soen, Shiro Tanaka, Yukari Uemura, Toshitsugu Sugimoto, Teruki Sone
We conducted a head-to-head randomized trial of minodronate, a bisphosphonate, and raloxifene, a selective estrogen receptor modulator, to obtain clinical evidence and information about their efficacy and safety. The Japanese Osteoporosis Interventio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22a6bc9e5cc9981e9e75e989fe85f017
Autor:
Eiji Itoi, Yasuo Ohashi, Hajime Orimo, Itsuo Gorai, Satoshi Mori, Toshitaka Nakamura, Hiroaki Ohta, Masataka Shiraki, Nobuaki Miyakawa, Masao Fukunaga, Toshitsugu Sugimoto, Yukari Uemura, Hiroshi Hagino, Shiro Tanaka, Takayuki Hosoi, Teruhiko Miyazaki
Publikováno v:
Journal of Bone and Mineral Metabolism. 35:385-395
The aim of this study was to investigate the efficacy of concurrent treatment with vitamin K2 and risedronate compared with treatment with risedronate alone in patients with osteoporosis and to explore subsets of patients for which concurrent treatme
Autor:
Hiroshi Hagino, Teruhiko Miyazaki, Takanori Yamamoto, Akiko Ishizuka, Takayuki Hosoi, Shiro Tanaka
Publikováno v:
Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku. 21:13-19
Autor:
Teruki Sone, Toshitsugu Sugimoto, Satoshi Soen, Masataka Shiraki, Toshitaka Nakamura, Mayumi Tsukiyama, Hiroshi Hagino, Masao Fukunaga, Satoshi Mori, Teruhiko Miyazaki, Yukari Uemura, Akira Taguchi, Shiro Tanaka, Hiroaki Ohta, Hajime Orimo
Publikováno v:
Journal of bone and mineral metabolism. 37(3)
We planned to conduct multi-center, open-labeled, blinded-endpoints, head-to-head randomized trial of minodronate and raloxifene to compare incidences of vertebral and non-vertebral fractures. The study is the Japanese Osteoporosis Intervention Trial
Autor:
Nobuaki Miyakawa, Tatsuhiko Kuroda, Masataka Shiraki, Yasuo Ohashi, Satoshi Mori, Hiroshi Hagino, Shiro Tanaka, Eiji Itoi, Hiroaki Ohta, Takayuki Hosoi, Masao Fukunaga, Teruhiko Miyazaki, Toshitsugu Sugimoto, Hajime Orimo, Yukari Uemura, Toshitaka Nakamura
Publikováno v:
Journal of Bone and Mineral Metabolism. 32:298-304
Concurrent treatments with bisphosphonates and vitamin K are promising given that bisphosphonates possibly interfere with vitamin K activation. This is a prospective, multi-center, open-labeled, randomized trial of the efficacy of concurrent treatmen
Autor:
Shiro, Tanaka, Teruhiko, Miyazaki, Yukari, Uemura, Nobuaki, Miyakawa, Itsuo, Gorai, Toshitaka, Nakamura, Masao, Fukunaga, Yasuo, Ohashi, Hiroaki, Ohta, Satoshi, Mori, Hiroshi, Hagino, Takayuki, Hosoi, Toshitsugu, Sugimoto, Eiji, Itoi, Hajime, Orimo, Masataka, Shiraki
Publikováno v:
Journal of bone and mineral metabolism. 35(4)
The aim of this study was to investigate the efficacy of concurrent treatment with vitamin K
Autor:
Satoshi Soen, Akira Taguchi, Hiroaki Ohta, Hajime Orimo, Mayumi Tsukiyama, Teruhiko Miyazaki, Toshitaka Nakamura, Masataka Shiraki
Publikováno v:
Calcified tissue international. 97(6)
Dentists request a discontinuation of antiresorptive agents, such as bisphosphonate, before and after tooth extractions to prevent osteonecrosis of the jaw (ONJ). However, little is known about how this affects ONJ and osteoporosis treatment and how
Publikováno v:
Nihon rinsho. Japanese journal of clinical medicine. 67(5)
A-TOP research consortium has been authorized at 2000 by the Japanese Society of Osteoporosis and assisted by Public Health Research Foundation in order to obtain the clinical evidences regarding osteoporosis treatment. Each clinical trial program wa